06/07/2026 Aurinia announced the initiation of a Phase 4 study investigating the combination of voclosporin and belimumab, obinutuzumab or anifrolumab in patients with LN Aurinia announced the initiation of a Phase 4 study investigating the combination of voclosporin and belimumab, obinutuzumab or anifrolumab in patients with LN (Ref) Aurinia Pharmaceuticals announced the initiation of the Phase 4, PRESERVE/ NCT07611214 study investigating the combination of LUPKYNIS® (voclos